Beijing Wantai Biological

ISIN CNE100004090

 | 

WKN A2QK68

Market cap (in EUR)
7,128 m
Country
China
Sector
Healthcare
Dividend yield
0.69%
 

Overview

Description

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.
Show more Show less
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices China

Financials

Key metrics

Market capitalisation, EUR 7,128 m
EPS, EUR -0.03
P/B ratio 4.9
P/E ratio 780.4
Dividend yield 0.69%

Income statement (2024)

Revenue, EUR 287 m
Net income, EUR 14 m
Profit margin 4.75%

What ETF is Beijing Wantai Biological in?

There are 22 ETFs which contain Beijing Wantai Biological. All of these ETFs are listed in the table below. The ETF with the largest weighting of Beijing Wantai Biological is the Goldman Sachs ActiveBeta® Emerging Markets Equity UCITS ETF CLASS USD (Acc.).
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI AC Far East ex-Japan UCITS ETF 0.01%
Equity
Asia Pacific
885
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.00%
Equity
World
Multi-Asset Strategy
865
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
14
iShares MSCI ACWI UCITS ETF USD (Acc) 0.00%
Equity
World
21,304
iShares MSCI EM UCITS ETF (Dist) 0.01%
Equity
Emerging Markets
6,132
UBS Core MSCI EM UCITS ETF USD dis 0.00%
Equity
Emerging Markets
1,904
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
64
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
186
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
662
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.01%
Equity
Emerging Markets
Social/Environmental
14
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0.00%
Equity
Emerging Markets
Social/Environmental
1,134
iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist) 0.00%
Equity
Emerging Markets
Social/Environmental
890
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Equity
World
26,565
Goldman Sachs ActiveBeta® Emerging Markets Equity UCITS ETF CLASS USD (Acc.) 0.10%
Equity
Emerging Markets
Multi-Factor Strategy
11
Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating 0.00%
Equity
Emerging Markets
1,350
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist 0.01%
Equity
Emerging Markets
808
Xtrackers Harvest CSI 300 UCITS ETF 1D 0.09%
Equity
China
274
Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
2,637
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
34
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
87
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
86
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Equity
World
18,591
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.